3 Glucagon and diabetes (Q35488423)

8 August 2017

1 reference

reason for preferred rank

title

3 Glucagon and diabetes (English)

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

14 December 2022

Glucagon and diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A142590

14 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

14 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

14 December 2022

author name string

S. Pek

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A142590

14 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=142590

14 December 2022

publication date

1 July 1977

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0300595X77800418?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

https://api.elsevier.com/content/article/PII:S0300595X77800418?httpAccept=text/plain

14 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

Clinics in Endocrinology and Metabolism

14 December 2022

published in

1 reference

8 August 2017

6

1 reference

8 August 2017

2

1 reference

8 August 2017

333-344

1 reference

Pancreatic Glucagon Secretion in Normal and Diabetic Subjects

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Inhibition of insulin secretion by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Role of glucagon and other hormones in development of diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Hepatic Autophagy in Uncontrolled Experimental Diabetes and Its Relationships to Insulin and Glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Normal glucagon response to arginine infusion in "prediabetic" Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Is glucagon important in stable insulin-dependent diabetics?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Pancreatectomised man: A model for diabetes without glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Gastric A-cell function in insulin-deprived depancreatized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

The Effect of Insulin on the Alpha-Cell Response to Hyperglycemia in Long-Standing Alloxan Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Glucagon release from isolated pancreas in streptozotocin-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Abnormalities of glucagon metabolism in untreated diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Letter: Glucagon antibodies in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Glucagon secretion in unaffected monozygotic twins of juvenile diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Abnormal Secretion of Insulin and Glucagon by the In Vitro Perfused Pancreas of the Genetically Diabetic Chinese Hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Interactions of polypeptide hormones with cell membrane specific receptors: Studies with insulin and glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Metabolic effects of long-term somatostatin infusion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Insulin and glucagon secretion by pancreatic islets from nondiabetic and diabetic sand rats (Psammomys obesus).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Determination of pancreatic and gut Glucagon-Like Immunoreactivity (GLI) in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Preparation of B Cell Deficient Guinea Pig Islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Heterogeneity of plasma glucagon in man

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Action of streptozotocin on insulin and glucagon responses of rat islets.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db/db)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Salivary gland hyperglycemic factor: an extrapancreatic source of glucagon-like material

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Diurnal Variations of Serum Insulin, Total Glucagon, Cortisol, Glucose and Free Fatty Acids in Normal and Diabetic Subjects before and after Treatment with Chlorpropamide

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Failure of somatostatin to correct manifest diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Persistent Pancreatic Glucagon but not Insulin Response to Arginine in Pancreatectomized Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Regulation of glucagon secretion of the diabetic pancreas in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Glucose, Insulin, Pancreatic Glucagon and Glucagon-like Immunoreactive Materials in the Plasma of Normal and Diabetic Children. Effect of the Initial Insulin Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

The effect of experimental insulin deficiency on glucagon secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Immunoreactive glucagon responses to arginine in three pancreatectomized humans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Identification of glucagon in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Studies of pancreatic alpha cell function in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

The essential role of glucagon in the pathogenesis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Heterogeneity of plasma immunoreactive glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon").

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Extrapancreatic glucagon in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

High Molecular Weight Glucagon-like Immunoreactivity in Plasma1

1 reference

https://api.crossref.org/works/10.1016%2FS0300-595X%2877%2980041-8

7 January 2021

Responses to arginine of the perfused pancreas of the genetically diabetic Chinese hamster

series ordinal

20

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

Plasma levels of growth hormone and glucagon in diabetic patients and relatives of diabetic patients

14 December 2022

series ordinal

34

1 reference

https://api.crossref.org/works/10.1016/S0300-595X(77)80041-8

14 December 2022

Identifiers

1 reference

8 August 2017

1 reference